National Prospective and Comparative Study on the Mode of Delivery of Twins

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8979 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-02-28

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the best obstetrical practices for twin delivery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prediction and Prevention of Twin Premature Birth 2021

NCT05061641

Preterm Birth

UNKNOWN PHASE4

Planned Vaginal Delivery vs Planned Cesarean Delivery in Preterm Twins

NCT04232436

Twin Pregnancy

COMPLETED

Recognition of Second Twin. Second Training vs Naive Performer. PROMPT Mannequin

NCT06127706

Twin Vaginal Delivery Skills

COMPLETED NA

Preterm Delivery Prevention in Twins With Progesterone

NCT01927029

Pregnancies

UNKNOWN PHASE4

Patient Satisfaction During Physiological Water or Land Birth: a Prospective Study in an French Tertiary Maternity Unit.

NCT06441370

Water Birth

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Large retrospective cohort studies have reported increased neonatal death and morbidity associated with vaginal delivery in comparison with cesarean in twin pregnancies. A recent large international randomized trial, the Twin Birth Study (TBS), showed that planned cesarean does not significantly decrease or increase the risk of fetal or neonatal death or serious neonatal morbidity, as compared with planned vaginal delivery in twin pregnancy between 32 and 39 weeks of gestation with a first twin in cephalic presentation. However, neither these large retrospective cohort studies, because information regarding delivery management is lacking, nor the TBS, because of insufficient statistical power, can answer the question on how to manage vaginal twin deliveries.

The aim of the JUMODA study is first to confirm in France whether planned vaginal delivery is not associated with increased neonatal risks in comparison with planned caesarean as shown in the TBS and secondly to determine the best obstetrical practices in case of vaginal delivery.

Analysis will be performed according to the planned mode of delivery (planned cesarean or planned vaginal delivery) and stratified according to:

1. Twin rank: second or first twin
2. Gestational age: before 28 weeks of gestation, before 32 weeks, after 32 weeks, and after 35 weeks
3. In the whole population and in low risk populations.

For women delivering vaginally, analysis will be stratified according to:
4. Second twin presentation: vertex or non vertex
5. Obstetrical manoeuvres: none, internal cephalic version, external cephalic version, total breech extraction

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnant Woman With Twins After 22 Weeks 0 Days of Gestation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pregnant woman with twins

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients delivering twins after 22 weeks and 0 days gestation in the participating maternities will be included in the study.

Exclusion Criteria

* Patients who expressed opposition to the use of personal medical data or medical data from their children for this research will not be included in the study

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No